Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 925 | 0 | 0 | 0 |
| Gross Profit | N/A | 925 | N/A | N/A | N/A |
| Operating Expenses | 22,180 | 21,059 | 18,779 | 14,733 | 15,219 |
| Operating Income | -22,180 | -20,134 | -18,779 | -14,733 | -15,219 |
| Interest Expense | 3 | 4 | 3 | 3 | 4 |
| Other Income | 1,966 | 1,646 | 1,861 | 17,119 | 646 |
| Pre-tax Income | -20,217 | -18,492 | -16,921 | 2,383 | -14,577 |
| Net Income Continuous | -20,217 | -18,492 | -16,921 | 2,383 | -14,577 |
| Net Income | $-20,217 | $-18,492 | $-16,921 | $2,383 | $-14,577 |
| EPS Basic Total Ops | -1.19 | -1.09 | -1.00 | 13.81 | -32.67 |
| EPS Basic Continuous Ops | -1.19 | -1.09 | -1.00 | 13.84 | -32.68 |
| EPS Diluted Total Ops | -1.19 | -1.09 | -1.00 | 13.81 | -32.67 |
| EPS Diluted Continuous Ops | -1.19 | -1.09 | -1.00 | 79.85 | -32.68 |
| EPS Diluted Before Non-Recurring Items | -1.19 | -1.09 | -1.00 | N/A | N/A |
| EBITDA(a) | $-22,061 | $-19,643 | $-18,400 | $-14,010 | $-14,391 |